OncotypeDX

Learn more about Genomic Health's diagnostic tests for breast, colon and prostate cancer, which can help patients and their doctor make better, more informed treatment decisions.

 

Until Every Woman Knows...

Oncotype DX for DCIS

DCIS / Stage 0 breast cancer affects 1 out of every 5 women diagnosed with breast cancer in the U.S. Not all DCIS patients will benefit from the addition of radiation therapy to their treatment. Learn more about the Oncotype DX test for DCIS.

Transforming the Treatment of Cancer

For over a decade, Genomic Health has made genomics an indispensable part of cancer care. Now, we are using next generation technology to transform patient management throughout the cancer journey: from diagnosis to treatment, and monitoring for recurrence. Learn more about how we are making cancer treatment smarter today and tomorrow.

Cancer Doors

Press Releases

August 4, 2015   

Genomic Health Announces Second Quarter 2015 Financial Results and Reports Record International and Prostate Cancer ...

July 30, 2015   

Urology Practice Publishes Study Showing Oncotype DX® Increases Use of Active Surveillance in Prostate Cancer P...

All press releases